Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma.

Sci Rep · 2026 · PMC12910012 · PMID 41690970

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)

( n = 10) was noted but did not reach statistical significance ( P = 0.07; Fig. 2 b).

also in 111,027 other papers

showed a trendno p-value reported

showed a trend toward better ocular relapse-free-survival than Rituximab itv.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.